1Ohkura H. Tumor markers in monitoring response to chemotherapy for patients with gastric cancer. Jpn J Clin Oncol, 1999, 29:525-526.
2Fujimura T,Kinami S,Ninomiya I,et al. Diagnostic Laparoscopy, Serum CA125, and Peritoneal Metastasis in Gastric Cancer. Endoscopy, 2002, 34:569-574.
同被引文献13
1Bast RJC Jr, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma [ J ]. J Clin Invest,1981,68(5) :1 331 - 1 337.
3Fan B ,Xiong B. Investigation of serum tumor markers in the diagnosis of gastric cancer [ J ]. Hepatogastroenterology, 2011,58(105) :239 -245.
4Fujinnwa T,Kinami S,Ninonfiya I,et al. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer [ J ]. Endoscopy,2002,34 (7) :569 - 574.
5Gubbels JA, Belisle J, Onda M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors [ J ]. Mol Cancer,2006,5( 1 ) :50.
6Kabawat SE, Bast RC Jr, Bhan AK, et al. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody 0C125 [ J ]. Int J Gynecol Pathol, 1983,2 (3) :275 - 285.
7Jcrgensen Jr. Targeted HER-2 treatment in advanced gastric cancer[ J ]. Oncology,2010,78 ( 1 ) :26 - 33.
